Related Experiment Video
Updated: Sep 12, 2025

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
Improvements in Serum 25(OH)D Following Stoss Dosing in People With Cystic Fibrosis and Variable Adherence to
Katelyn Gordon1,2, Cole G Chapman3, Nichole M Harklau4
1Department of Pharmaceutical Care University of Iowa Hospitals and Clinics Iowa City Iowa USA.
Background And Aims:
People with cystic fibrosis (pwCF) often have vitamin D deficiency and require vitamin D supplementation. The primary objective of this study was to evaluate the impact of ultrahigh dose cholecalciferol ("stoss dosing") in pwCF with variable adherence to maintenance cholecalciferol.
Methods:
Retrospective cohort study of pwCF who received initial stoss dose per protocol between January 2017 and November 2021 at University of Iowa Health Care adult and pediatric CF centers. Serum 25(OH)D concentrations were extracted from the EMR. The increase in serum 25(OH)D concentration associated with receiving stoss doses was evaluated using a longitudinal linear mixed effects regression model.
Results:
Fifty-eight patients were included in the final analysis. The mean baseline 25(OH)D concentration before stoss therapy was 20.1 ng/mL (standard deviation [SD] = 5.9). The mean serum 25(OH)D concentration following stoss therapy increased to 27.9 ng/mL (SD = 7.5) and was measured on average 116 days after stoss administration. For patients with self-reported non-adherence to vitamin regimens, 16 out of 20 (80%) achieved a serum 25(OH)D concentration of at least 30 ng/mL after stoss therapy.
Conclusions:
Our findings suggest that stoss dosing was associated with increased serum 25(OH)D concentrations. This benefit also existed for individuals with self-reported non-adherence to maintenance cholecalciferol regimens with most patients reaching concentration goals.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
08:42Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Steady State Concentration
Most drugs are administered in repeated doses at fixed intervals or through continuous...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...